Peijia Medical Ltd is an investment holding company principally engaged in the provision of interventional procedural medical device. The Company primarily operates its businesses through two segments, Transcatheter Valve Therapeutic Business segment and Neurointerventional Business segment. Transcatheter Valve Therapeutic Business segment is mainly engaged in the business of research and development, manufacturing and sales of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is mainly involved in the business of research and development, manufacturing and sales of neurointerventional procedural medical devices. The Company’s products include commercialized products such as TaurusOne and TaurusElite. The Company mainly conducts its businesses in the domestic market. *
Please click to see notes of Issued Shares.Issued Shares (excluding treasury shares)
669,512,908 (as at 30 Jun 2025)
Industry
Healthcare - Healthcare Equipment & Services - Medical Devices & Supplies Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the . (HSIC)
Industry Classification (CSIC) is provided by China Securities Indexes Co., Ltd. and only available for companies dually listed in Hong Kong and Shanghai. Please see the . (CSIC)
Listing Date
15 May 2020
Financial Year Ends
31 Dec 2024
Chairman
Yi Zhang
Principal Office
Room 1901, 19/F
Lee Garden One
33 Hysan Avenue
Causeway Bay, Hong Kong
Place of Incorporation
Cayman Islands
Listing Category
Primary Listing
Primary Market
Depositary
DR Ratio
Description
Amount Outstanding
-
-
Subscription Rights per Unit
Subscription price/Strike price
Listing Date
The entitlement ratio in general represents the number of warrants required to be exercised into one share or one unit of the underlying asset (subject to any adjustments as may be necessary to reflect any capitalization, rights issue, distribution or the like).Entitlement Ratio
Subscription Period
Underlying Stock Code
Trading Currency